AVON MESOTHELIOMA FOUNDATION
fund research into Mesothelioma, we have a cople of projects we have applied for approval but have yet to hear the outcome
Objects
1. TO PROTECT AND PROMOTE THE HEALTH OF THE PUBLIC, IN PARTICULAR BY RESEARCH INTO THE NATURE, CAUSES, DIAGNOSIS, PREVENTION, TREATMENT AND CURE OF ALL FORMS OF DISEASE CAUSED BY OR PARTLY BY INHALATION OF ASBESTOS FIBRES, INCLUDING THE DEVELOPMENT OF RESEARCH FINDINGS INTO PRACTICAL APPLICATIONS FOR THE PREVENTION, TREATMENT AND CURE OF SUCH DISEASES.2. TO PROMOTE AND PROTECT THE PHYSICAL AND MENTAL HEALTH OF SUFFERERS OF DISEASE CAUSED BY OR PARTLY BY INHALATION OF ASBESTOS FIBRES, AND THEIR RELATIVES, THROUGH THE PROVISION OF FINANCIAL ASSISTANCE, SUPPORT, EDUCATION AND PRACTICAL ADVICE.3. TO RELIEVE SICKNESS AND TO PRESERVE THE HEALTH OF SUFFERERS OF DISEASE CAUSED BY OR PARTLY BY INHALATION OF ASBESTOS FIBRES, BY PROVIDING OR ASSISTING IN THE PROVISION OF EQUIPMENT, FACILITIES AND SERVICES ANCILLARY TO THOSE PROVIDED BY THE NATIONAL HEALTH SERVICE.4. TO ADVANCE THE EDUCATION OF THE GENERAL PUBLIC IN ALL AREAS RELATING TO DISEASE CAUSED BY OR PARTLY BY INHALATION OF ASBESTOS FIBRES.
Financial health, per its FY2024 accounts
The accounts state that the trustees agreed to maintain a reserve balance of at least £50,000 before spending funds. The document reports no funds materially in deficit and details specific grants awarded for research projects. However, the provided text is limited to the Trustees' Annual Report and does not contain the full financial statements required to assess total income, expenditure, or unrestricted reserves.
What the accounts disclose
“The Trustees had agreed to ensure a balance of £50 000 before spending any money from the AMF funds.” — page 5
Annual return filing dates (Charity Commission record)
Of its last 5 annual returns with a recorded received date, 3 were received after the due date: year ending 20/12/2024 (received 18/12/2025, 59 days after the 20/10/2025 due date); year ending 20/12/2023 (received 29/10/2024, 9 days after the 20/10/2024 due date); year ending 20/12/2022 (received 03/05/2024, 196 days after the 20/10/2023 due date).
Trustees
- John Ellis Harveychair
- Anna Jane Morley
- Deborah Jane Walton
- Dr NAJIB MAHBOOB RAHMAN
- Dr Nick Maskell Professor
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 20/12/2025 | £3k | £833 |
| 20/12/2024 | £34k | £46k |
| 20/12/2023 | £15k | £216 |
| 20/12/2022 | £10k | £30k |
| 20/12/2021 | £16k | £432 |
Common questions
Is AVON MESOTHELIOMA FOUNDATION financially healthy?
Per its FY2024 accounts: The accounts state that the trustees agreed to maintain a reserve balance of at least £50,000 before spending funds. The document reports no funds materially in deficit and details specific grants awarded for research projects. However, the provided text is limited to the Trustees' Annual Report and does not contain the full financial statements required to assess total income, expenditure, or unrestricted reserves.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE CAPRICORN FOUNDATION | 1 | £275k |
| THE RICHARD KIRKMAN TRUST | 1 | £27k |
| EARL OF CHICHESTER'S CHARITABLE TRUST | 1 | £200 |
Charities like this
- JUNE HANCOCK MESOTHELIOMA RESEARCH FUND
- THE MIDDLETON FOUNDATION
- THE VAN MESDAG FUND
- WESSEX MEDICAL TRUST
- THE MICHAEL COWAN FOUNDATION
- TRUST FOR DEAF STUDIES
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| AVON MESOTHELIOMA FOUNDATION | £3k | — | — | unclear | — | no doubt |
| JUNE HANCOCK MESOTHELIOMA RESEARCH FUND | £47k | — | 0 | above | — | no doubt |
| THE MIDDLETON FOUNDATION | £145k | — | 0 | within | — | no doubt |
| THE VAN MESDAG FUND | £93k | — | 0 | above | — | no doubt |
| WESSEX MEDICAL TRUST | £182k | — | 0 | unclear | — | no doubt |
| THE MICHAEL COWAN FOUNDATION | £2.0m | — | 0 | unclear | — | no doubt |